Literature DB >> 26760180

A Retrospective Review of Treatment Failures Using Azithromycin and Doxycycline in the Treatment of Rectal Chlamydia Infections in Women and Men Who Have Sex With Men.

Jennifer Gratrix1, Judith Brandley, Marla Dane, Sabrina S Plitt, Petra Smyczek, Ron Read, Ameeta E Singh.   

Abstract

We examined the prevalence of rectal chlamydia treatment failures in men who have sex with men and women attending Alberta sexually transmitted infection clinics. Among those completing a test of cure, there was no significant difference among patients treated initially with azithromycin (treatment failure, 39/460 [8.5%]; 95% confidence interval, 5.9%-11.0%) compared with patients treated with doxycycline (0/16; 95% confidence interval, 0%-0.2%; P = 0.63).

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26760180     DOI： 10.1097/OLQ.0000000000000403

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


  6 in total

1.  Sexually Transmitted Infections in the Context of HIV Disease: Clinical Implications.

Authors:  Dana W Dunne
Journal:  Top Antivir Med       Date:  2016 Oct/Nov

2.  Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

Authors:  William M Geisler; Jane S Hocking; Toni Darville; Byron E Batteiger; Robert C Brunham
Journal:  Clin Infect Dis       Date:  2022-04-13       Impact factor: 9.079

Review 3.  Immunopathogenesis of genital Chlamydia infection: insights from mouse models.

Authors:  Jacob Dockterman; Jörn Coers
Journal:  Pathog Dis       Date:  2021-03-31       Impact factor: 3.951

4.  Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol.

Authors:  Andrew Lau; Fabian Kong; Christopher K Fairley; Basil Donovan; Marcus Chen; Catriona Bradshaw; Mark Boyd; Janaki Amin; Peter Timms; Sepehr Tabrizi; David G Regan; David A Lewis; Anna McNulty; Jane S Hocking
Journal:  BMC Infect Dis       Date:  2017-01-06       Impact factor: 3.090

5.  Epidemiology, molecular characterisation and antimicrobial susceptibility of Neisseria gonorrhoeae isolates in Madrid, Spain, in 2016.

Authors:  M D Guerrero-Torres; M B Menéndez; C S Guerras; E Tello; J Ballesteros; P Clavo; T Puerta; M Vera; O Ayerdi; J C Carrio; I Mozo; J Del Romero; J A Vázquez; R Abad
Journal:  Epidemiol Infect       Date:  2019-09-24       Impact factor: 2.451

6.  Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure).

Authors:  Nicole H T M Dukers-Muijrers; Petra F G Wolffs; Henry De Vries; Hannelore M Götz; Titia Heijman; Sylvia Bruisten; Lisanne Eppings; Arjan Hogewoning; Mieke Steenbakkers; Mayk Lucchesi; Maarten F Schim van der Loeff; Christian J P A Hoebe
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.